Summary
This methodological paper addresses a critical limitation in Mendelian randomization—the requirement that all genetic variants be valid instrumental variables—by introducing a weighted median estimator robust to invalid instruments. The authors demonstrate through simulation that their estimator maintains consistent estimates when up to 50% of information derives from invalid variants and exhibits superior Type 1 error control compared to standard inverse-variance weighting. Application to lipid-cardiovascular disease data illustrates how the weighted median method can correct misleading causal inferences, particularly regarding high-density lipoprotein cholesterol effects.
UK applicability
This methodological advance is applicable to UK researchers and clinicians using Mendelian randomization to infer causal relationships between genetic variants, biomarkers, and disease outcomes. The method strengthens the reliability of genetic epidemiological evidence informing UK health policy and clinical practice by reducing bias from invalid genetic instruments.
Key measures
Type 1 error rates; consistency of causal estimates; performance of weighted median estimator versus inverse-variance weighted method and MR-Egger regression
Outcomes reported
The study developed and evaluated a weighted median estimator for Mendelian randomization that remains consistent even when up to 50% of genetic variants are invalid instrumental variables. The method was tested through simulation and applied to analyses of lipid fractions and coronary artery disease risk.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.